216 related articles for article (PubMed ID: 34418472)
1. Dry powder inhaler formulation comparison: Study of the role of particle deposition pattern and dissolution.
Noriega-Fernandes B; Malmlöf M; Nowenwik M; Gerde P; Corvo ML; Costa E
Int J Pharm; 2021 Sep; 607():121025. PubMed ID: 34418472
[TBL] [Abstract][Full Text] [Related]
2. Effect of particle deposition density of dry powders on the results produced by an in vitro test system simulating dissolution- and absorption rates in the lungs.
Malmlöf M; Nowenwik M; Meelich K; Rådberg I; Selg E; Burns J; Mascher H; Gerde P
Eur J Pharm Biopharm; 2019 Jun; 139():213-223. PubMed ID: 30862480
[TBL] [Abstract][Full Text] [Related]
3. Formulation of novel dry powder inhalation for fluticasone propionate and salmeterol xinafoate with capsule-based device.
Kim KS; Kim JH; Jin SG; Kim DW; Kim JO; Yong CS; Youn YS; Oh KT; Woo JS; Choi HG
Pharm Dev Technol; 2018 Feb; 23(2):158-166. PubMed ID: 28612675
[TBL] [Abstract][Full Text] [Related]
4. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate.
Kumar V; Sethi B; Yanez E; Leung DH; Ghanwatkar YY; Cheong J; Tso J; Narang AS; Nagapudi K; Mahato RI
Int J Pharm; 2022 Mar; 615():121470. PubMed ID: 35041913
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and pharmacodynamics of fluticasone propionate and salmeterol delivered as a combination dry powder from a capsule-based inhaler and a multidose inhaler in asthma and COPD patients.
Daley-Yates PT; Mehta R; Chan RH; Despa SX; Louey MD
J Aerosol Med Pulm Drug Deliv; 2014 Aug; 27(4):279-89. PubMed ID: 24074143
[TBL] [Abstract][Full Text] [Related]
6. Understanding the Impacts of Surface Compositions on the In-Vitro Dissolution and Aerosolization of Co-Spray-Dried Composite Powder Formulations for Inhalation.
Mangal S; Xu R; Park H; Zemlyanov D; Shetty N; Lin YW; Morton D; Chan HK; Li J; Zhou QT
Pharm Res; 2018 Nov; 36(1):6. PubMed ID: 30406281
[TBL] [Abstract][Full Text] [Related]
7. Agglomerate behaviour of fluticasone propionate within dry powder inhaler formulations.
Le VN; Robins E; Flament MP
Eur J Pharm Biopharm; 2012 Apr; 80(3):596-603. PubMed ID: 22198291
[TBL] [Abstract][Full Text] [Related]
8. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
Jetzer MW; Schneider M; Morrical BD; Imanidis G
J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
[TBL] [Abstract][Full Text] [Related]
9. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
[TBL] [Abstract][Full Text] [Related]
10. Optical photothermal infrared spectroscopy for nanochemical analysis of pharmaceutical dry powder aerosols.
Khanal D; Kim J; Zhang J; Ke WR; Holl MMB; Chan HK
Int J Pharm; 2023 Feb; 632():122563. PubMed ID: 36586629
[TBL] [Abstract][Full Text] [Related]
11. A quantitative approach to predicting lung deposition profiles of pharmaceutical powder aerosols.
Yaqoubi S; Chan HK; Nokhodchi A; Dastmalchi S; Alizadeh AA; Barzegar-Jalali M; Adibkia K; Hamishehkar H
Int J Pharm; 2021 Jun; 602():120568. PubMed ID: 33812969
[TBL] [Abstract][Full Text] [Related]
12. Focusing on powder processing in dry powder inhalation product development, manufacturing and performance.
Stegemann S; Faulhammer E; Pinto JT; Paudel A
Int J Pharm; 2022 Feb; 614():121445. PubMed ID: 34998921
[TBL] [Abstract][Full Text] [Related]
13. Effect of USP Induction Ports, Glass Sampling Apparatus, and Inhaler Device Resistance on Aerodynamic Patterns of Fluticasone Propionate-Loaded Engineered Mannitol Microparticles.
Mehta P; Bothiraja C; Kadam S; Pawar A
AAPS PharmSciTech; 2019 May; 20(5):197. PubMed ID: 31123855
[TBL] [Abstract][Full Text] [Related]
14. Physico-Chemical Properties, Aerosolization and Dissolution of Co-Spray Dried Azithromycin Particles with L-Leucine for Inhalation.
Mangal S; Nie H; Xu R; Guo R; Cavallaro A; Zemlyanov D; Zhou QT
Pharm Res; 2018 Jan; 35(2):28. PubMed ID: 29374368
[TBL] [Abstract][Full Text] [Related]
15. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
Li J; Ma S; He X; Sun Y; Zhang X; Guan J; Mao S
Int J Pharm; 2023 Jul; 642():123179. PubMed ID: 37364785
[TBL] [Abstract][Full Text] [Related]
16. Spray-Dried PulmoSphere™ Formulations for Inhalation Comprising Crystalline Drug Particles.
Weers JG; Miller DP; Tarara TE
AAPS PharmSciTech; 2019 Feb; 20(3):103. PubMed ID: 30734187
[TBL] [Abstract][Full Text] [Related]
17. Assessment of Dry Powder Inhaler Carrier Targeted Design: A Comparative Case Study of Diverse Anomeric Compositions and Physical Properties of Lactose.
Pinto JT; Zellnitz S; Guidi T; Roblegg E; Paudel A
Mol Pharm; 2018 Jul; 15(7):2827-2839. PubMed ID: 29856921
[TBL] [Abstract][Full Text] [Related]
18. Powder dispersion mechanisms within a dry powder inhaler using microscale particle image velocimetry.
Kou X; Wereley ST; Heng PW; Chan LW; Carvajal MT
Int J Pharm; 2016 Dec; 514(2):445-455. PubMed ID: 27497998
[TBL] [Abstract][Full Text] [Related]
19. Can Pharmacokinetic Studies Assess the Pulmonary Fate of Dry Powder Inhaler Formulations of Fluticasone Propionate?
Hochhaus G; Chen MJ; Kurumaddali A; Schilling U; Jiao Y; Drescher SK; Amini E; Berger SM; Kandala B; Tabulov C; Shao J; Seay B; Abu-Hasan MN; Baumstein SM; Winner L; Shur J; Price R; Hindle M; Wei X; Carrasco C; Sandell D; Oguntimein O; Kinjo M; Delvadia R; Saluja B; Lee SL; Conti DS; Bulitta JB
AAPS J; 2021 Mar; 23(3):48. PubMed ID: 33768368
[TBL] [Abstract][Full Text] [Related]
20. Dry powder inhaler performance of spray dried mannitol with tailored surface morphologies as carrier and salbutamol sulphate.
Mönckedieck M; Kamplade J; Fakner P; Urbanetz NA; Walzel P; Steckel H; Scherließ R
Int J Pharm; 2017 May; 524(1-2):351-363. PubMed ID: 28347847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]